Recent advances and trends in nanoparticles based photothermal and photodynamic therapy.


Journal

Photodiagnosis and photodynamic therapy
ISSN: 1873-1597
Titre abrégé: Photodiagnosis Photodyn Ther
Pays: Netherlands
ID NLM: 101226123

Informations de publication

Date de publication:
Mar 2022
Historique:
received: 28 08 2021
revised: 14 12 2021
accepted: 14 12 2021
pubmed: 23 12 2021
medline: 9 3 2022
entrez: 22 12 2021
Statut: ppublish

Résumé

Light-mediated therapies, including photodynamic therapy (PDT) and photothermal therapy (PTT) have been exploited as minimally invasive techniques for ablation of various tumors., Both modalities may eradicate tumors with minimal side effects to normal tissues and organs. Moreover, developments of light-mediated approaches using nanoparticles (NPs) and photosensitizer (PS) as diagnostic and therapeutic agents may have a crucial role in achieving successful cancer treatment. In recent years, novel nanoplatforms and strategies have been investigated to boost the therapeutic effect.. In this regard, gold, iron oxide, graphene oxide nanoparticles and hybrid nanocomposites have attracted attention.. Moreover, the combination of these materials with PS, in the form of hybrid NPs, reduces in vitro and in vivo normal tissue cytotoxicity, improves their solubility property in the biological environment and enhances the therapeutic effects. In this review, we look into the basic principles of PTT and PDT with their strengths and limitations to treat cancers. We also will discuss light-based nanoparticles and their PTT and PDT applications in the preclinical and clinical translation. Also, recent advances and trends in this field will be discussed along with the clinical challenges of PTT and PDT.

Identifiants

pubmed: 34936918
pii: S1572-1000(21)00514-7
doi: 10.1016/j.pdpdt.2021.102697
pii:
doi:

Substances chimiques

Photosensitizing Agents 0
Gold 7440-57-5

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

102697

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Auteurs

Jamileh Kadkhoda (J)

Research Center for Pharmaceutical Nanotechnology, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Medicinal Chemistry, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.

Ali Tarighatnia (A)

Department of Medical Physics and Biomedical Engineering, Tehran University of Medical Sciences, Tehran, Iran.

Jaleh Barar (J)

Research Center for Pharmaceutical Nanotechnology, Tabriz University of Medical Sciences, Tabriz, Iran.

Ayuob Aghanejad (A)

Research Center for Pharmaceutical Nanotechnology, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: Aghanejaday@tbzmed.ac.ir.

Soodabeh Davaran (S)

Research Center for Pharmaceutical Nanotechnology, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Medicinal Chemistry, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: davaran@tbzmed.ac.ir.

Articles similaires

Humans Hyaluronic Acid Osteoarthritis, Hip Female Middle Aged
Tumor Microenvironment Nanoparticles Immunotherapy Cellular Senescence Animals

Necroptosis as a consequence of photodynamic therapy in tumor cells.

Álvaro Carneiro de Souza, André Luiz Mencalha, Adenilson de Souza da Fonseca et al.
1.00
Photochemotherapy Humans Necroptosis Neoplasms Photosensitizing Agents
Cobalt Azo Compounds Ferric Compounds Polyesters Photolysis

Classifications MeSH